Table 4:
Red blood cell, white blood cell count, and hemostatic factor associations (p<0.01).
| Marker | Gene | Allele | Phenotype | Effect | p-value |
|---|---|---|---|---|---|
| rs9996294 | RAPGEF2 | G | RBC Phase 2 | −6.04 | 9.97×10−3 |
| D-dimer Phase 2 | 0.42 | 9.50×10−3 | |||
| Gold D-dimer Phase 2 | 0.38 | 7.40×10−3 | |||
| Hemoglobin Phase 2 | −2.49 | 5.12×10−4 | |||
| Hematocrit Phase 2 | −0.69 | 1.07×10−3 | |||
| rs342286 | PIK3CG | G | Hemoglobin Phase 2 | −1.25 | 9.30×10−3 |
| Monocyte Count Phase 2a | 0.04 | 1.07×10−3 | |||
| RBC Phase 3 | −4.65 | 3.54×10−3 | |||
| rs12359150 | CUBN | A | Monocyte Count Phase 3a | 0.25 | 3.91×10−5 |
| rs4128880 | RGS18 | C | Hematocrit Phase 3a | −0.60 | 4.38×10−3 |
a
Under recessive model; Abbreviations: RBC, red blood cell count